These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 17374349)
1. [Prospective observational study of drug-induced hyperkalemia in hospitalized non dialized adult patients]. Onno C; Rémignon H; Lagarce L; Bruhat C; Tourmen Y; Subra JF; Lainé-Cessac P Therapie; 2007; 62(1):55-60. PubMed ID: 17374349 [TBL] [Abstract][Full Text] [Related]
2. [Prospective observational study of angiotensin converting enzyme inhibitors-induced hyperkalemia in hospitalized patients with chronic renal failure]. Ben Mahmoud L; Ghozzi H; Kammoun K; Hakim A; Kharrat M; Ben Hmida M; Jarraya F; Sahnoun Z; Zeghal K; Hachicha J Nephrol Ther; 2013 Apr; 9(2):98-102. PubMed ID: 23022289 [TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system blockade is not associated with hyperkalemia in chronic hemodialysis patients. Lin HH; Yang YF; Chang JK; Ting IW; Kuo HL; Wang IK; Huang CC Ren Fail; 2009; 31(10):942-5. PubMed ID: 20030530 [TBL] [Abstract][Full Text] [Related]
4. Hyperkalemia in an adult hospitalized population. Borra S; Shaker R; Kleinfeld M Mt Sinai J Med; 1988 May; 55(3):226-9. PubMed ID: 3260990 [No Abstract] [Full Text] [Related]
5. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. Noize P; Bagheri H; Durrieu G; Haramburu F; Moore N; Giraud P; Galinier M; Pourrat J; Montastruc JL Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):747-53. PubMed ID: 21438068 [TBL] [Abstract][Full Text] [Related]
6. Clinical factors associated with hyperkalemia in patients with congestive heart failure. Ramadan FH; Masoodi N; El-Solh AA J Clin Pharm Ther; 2005 Jun; 30(3):233-9. PubMed ID: 15896240 [TBL] [Abstract][Full Text] [Related]
7. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice. Onuigbo MA Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421 [TBL] [Abstract][Full Text] [Related]
8. Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Raebel MA; Ross C; Cheetham C; Petersen H; Saylor G; Smith DH; Wright LA; Roblin DW; Xu S Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):19-25. PubMed ID: 19937982 [TBL] [Abstract][Full Text] [Related]
9. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone. Abbas Z; Mumtaz K; Salam A; Jafri W J Coll Physicians Surg Pak; 2003 Jul; 13(7):382-4. PubMed ID: 12887837 [TBL] [Abstract][Full Text] [Related]
10. Heparin-induced hyperkalemia: a prospective study. González-Martin G; Díaz-Molinas MS; Martínez AM; Ortiz M Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):446-50. PubMed ID: 1800392 [TBL] [Abstract][Full Text] [Related]
11. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis. Onuigbo MA; Onuigbo NT QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475 [TBL] [Abstract][Full Text] [Related]
12. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome. Gotsman I; Rubonivich S; Azaz-Livshits T Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235 [TBL] [Abstract][Full Text] [Related]
13. The management of hyperkalemia in patients with cardiovascular disease. Khanna A; White WB Am J Med; 2009 Mar; 122(3):215-21. PubMed ID: 19272479 [TBL] [Abstract][Full Text] [Related]
14. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia? Raebel MA; McClure DL; Chan KA; Simon SR; Feldstein AC; Lafata JE; Andrade SE; Gunter MJ; Nelson WW; Roblin D; Platt R Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506 [TBL] [Abstract][Full Text] [Related]
15. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience. Onuigbo MA; Onuigbo NT Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908 [TBL] [Abstract][Full Text] [Related]
17. Adverse biochemical and clinical consequences of furosemide administration. Spino M; Sellers EM; Kaplan HL; Stapleton C; MacLeod SM Can Med Assoc J; 1978 Jun; 118(12):1513-8. PubMed ID: 657047 [TBL] [Abstract][Full Text] [Related]
18. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Wong CF; McCarthy M; Howse ML; Williams PS Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158 [TBL] [Abstract][Full Text] [Related]
19. The Model for End-stage Liver Disease score is potentially a useful predictor of hyperkalemia occurrence among hospitalized angiotensin receptor blocker users. Sheen SS; Park RW; Yoon D; Shin GT; Kim H; Park IW J Clin Pharm Ther; 2015 Feb; 40(1):48-54. PubMed ID: 25328056 [TBL] [Abstract][Full Text] [Related]